Genetic Testing

Donna McDonald-McGinn, Director of the 22q and You Center, received a Dedication to Service award for her lifelong 22q11.2 deletion syndrome work.

Researchers’ report reveals RIMGC’s successful, centralized approach to genomic testing, treatment, and management.

The Epilepsy NeuroGenetics Initiative is bridging the gap between advances in genetic discovery and improvements in treatment.

Roberts Individualized Medical Genetics Center’s new large genetic database and portal is now accessible to all CHOP investigators.

A new model for genomic test interpretation and continuous reanalysis may enable faster, systematic, and more effective use of new discoveries.

This is the first generation where women are routinely tested for genetic mutations that may increase their risk for breast cancer. They are also increasingly aware of the implications of their cancer history and genetic testing results on their daughters.